Hypothesis

Tissue-specific microRNA-mediated repression of ZMPSTE24 drives age‑dependent prelamin A accumulation in vascular smooth muscle, leading to CK2α sequestration and senescence.

Mechanistic basis

Recent work shows that prelamin A, not progerin, accumulates with declining ZMPSTE24 activity and directly binds CK2α, reducing its kinase activity and promoting senescence [2]. Aorta, heart and fat exhibit lamin A/C half‑lives an order of magnitude longer than liver or intestine [3], creating a window where reduced ZMPSTE24 translation can shift the lamin A processing balance. We hypothesize that vascular‑enriched microRNAs (e.g., miR-143/145 cluster) bind the 3′‑UTR of ZMPSTE24 mRNA, lowering its expression specifically in smooth muscle cells. This post‑transcriptional repression would produce a gradual rise in farnesylated prelamin A that sequesters CK2α at the nuclear envelope, dampening CK2‑dependent phosphorylation of substrates such as lamin B1 and histone H2B, thereby impairing DNA repair and promoting senescence.

Novel insight

Beyond the CK2α route, we propose that prelamin A‑induced changes in nuclear lamina mechanics alter the accessibility of chromatin domains tethered to LADs (lamina‑associated domains). Increased nuclear stiffness in prelamin A‑rich cells could hinder the movement of repair factors to sites of DNA damage, creating a CK2‑independent contribution to genomic instability.

Testable Predictions

1. Vascular smooth muscle from aged humans will show higher levels of miR-143/145 and lower ZMPSTE24 protein compared with liver or intestinal tissue.
2. Antagonizing miR-143/145 in cultured human aortic smooth muscle cells will rescue ZMPSTE24 expression, reduce prelamin A accumulation, restore CK2α kinase activity, and decrease senescence markers (SA‑β‑gal, p16).
3. Expressing a CK2α‑binding‑deficient prelamin A mutant (e.g., K557A) in the Lmna^L648R/L648R mouse will ameliorate senescence without altering nuclear stiffness, isolating the CK2‑dependent arm.
4. Measuring nuclear recoil after localized laser‑induced DNA damage will reveal slower repair factor accumulation in prelamin A‑high cells, a defect that persists even when CK2α activity is pharmacologically restored.

Experimental Approach

• Human tissue analysis: qPCR for miR-143/145, western blot for ZMPSTE24 and prelamin A in aorta, heart, fat, liver, intestine from donors stratified by age.
• Loss‑of‑function: Transfect aortic smooth muscle cells with miR-143/145 antagomirs; assess ZMPSTE24 by immunoblot, prelamin A by farnesyl‑specific CK2α activity assay, senescence by flow cytometry for C12FDG.
• Mouse models: Cross Lmna^L648R/L648R mice with a transgenic line expressing prelamin A K557A; evaluate aortic histology, PWV (pulse wave velocity), and lifespan.
• DNA repair kinetics: Live‑cell imaging of 53BP1‑GFP recruitment after microirradiation in primary smooth muscle cells treated with spermidine (CK2 activator) versus vehicle.

If miR‑mediated ZMPSTE24 suppression is validated, it would explain why cardiovascular tissues age faster despite ubiquitous lamin A expression and would point to microRNA‑based therapeutics as a means to delay lamina‑driven aging.